Written question asked by Gregory Campbell (Democratic Unionist Party) on Wednesday, 1 May 2024, in the House of Commons. It was due for an answer on Tuesday, 7 May 2024 (named day). It was answered by Andrew Stephenson (Conservative) on Tuesday, 7 May 2024 on behalf of the Department of Health and Social Care.

Streptococcus: Clinical Trials

Question: To ask the Secretary of State for Health and Social Care, whether she expects to receive the outcome of the Group B Streptococcus trial before the House rises for the Summer adjournment.

Answer: The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations trial current contract end date is 31 August 2025, therefore results will not be available before the House of Commons rises for the summer adjournment. The trial has finished recruiting participants and data extraction and analysis continues and the results will be available once both are completed. As with all research funded through the National Institute for Health and Care Research, we expect findings to be submitted to the Department, and in the case of this trial, to the UK National Screening Committee (UK NSC) hosted by the Department. The UK NSC stands ready to review the findings of this research as soon as the results are shared.

Secondary information